If a Learningrx franchisee is an entity, what attachment must be completed and updated?
Learningrx Franchise · 2025 FDDAnswer from 2025 FDD Document
ATTACHMENT VII TO FRANCHISE AGREEMENT
New Franchisee Disclosure Questionnaire
As you know, you and LearningRx Franchise Corporation are preparing to enter into a Franchise Agreement for the operation of a LearningRx franchise. This questionnaire cannot be signed and dated the same day as the Acknowledgment for the Franchise Disclosure Document.
If you are a franchisee in any of the following states, please do not answer Questions 4 or 11 – 15, as such questions are not applicable to you: California, Hawaii, Illinois, Indiana, Maryland, Michigan, Minnesota, New York, North Dakota, Rhode Island, South Dakota, Virginia, Washington, or Wisconsin
Do not sign this Questionnaire if you are a resident of California, Maryland or Washington, or your business will be operated in the states of California, Maryland or Washington.
All Representations requiring prospective franchisees to assent to a release, estoppel or waiver of liability are not intended to nor shall they act as a release, estoppel or waiver of any liability incurred under the Maryland Franchise Registration and Disclosure Law
This Questionnaire does not waive any liability LearningRx may have under the Washington Franchise Investment Protection Act, RCW 19.100, and the rules adopted thereunder.
Please review each of the following questions carefully and provide honest responses to each question. If you answer "No" to any of the questions below, please explain your answer on the back of this sheet.
Source: Item 23 — RECEIPT (FDD pages 54–209)
What This Means (2025 FDD)
According to the 2025 Learningrx Franchise Disclosure Document, prospective franchisees must complete the 'New Franchisee Disclosure Questionnaire,' which is designated as Attachment VII to the Franchise Agreement. This questionnaire is a crucial step in the process of becoming a Learningrx franchisee. The document explicitly states that the questionnaire cannot be signed and dated on the same day as the Acknowledgment for the Franchise Disclosure Document, emphasizing the importance of careful review and consideration.
However, the document also notes some caveats regarding the questionnaire. Franchisees in California, Hawaii, Illinois, Indiana, Maryland, Michigan, Minnesota, New York, North Dakota, Rhode Island, South Dakota, Virginia, Washington, or Wisconsin are instructed not to answer Questions 4 or 11-15, as those questions are not applicable to them. Furthermore, residents of California, Maryland, or Washington, or those operating their Learningrx business in those states, are instructed not to sign the questionnaire at all.
The FDD includes specific statements to ensure compliance with state franchise laws. For instance, it clarifies that any representations requiring franchisees to release, waive, or estop liability do not apply under Maryland's Franchise Registration and Disclosure Law. Similarly, the questionnaire does not waive any liability Learningrx may have under the Washington Franchise Investment Protection Act. These stipulations highlight the importance of understanding state-specific regulations when investing in a Learningrx franchise.
Prospective franchisees should carefully review Attachment VII and understand which questions apply to their specific situation based on their state of residence and where they intend to operate their Learningrx center. They should also be aware of the legal protections afforded to them under state franchise laws, as outlined in the FDD.